COM:ENDRAINC
ENDRA Life Sciences Inc.
- Stock
Last Close
0.42
30/08 20:00
Market Cap
6.18M
Beta: -
Volume Today
3.20M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 169.00K - | 69.55K 58.84% | 115.89K 66.62% | 125.56K 8.34% | 86.44K 31.16% | 351.53K 306.66% | 937.10K 166.58% | 1.96M 109.65% | 2.63M 34.06% | ||
average payables | 46.22K - | 154.34K 233.92% | 504.00K 226.54% | 705.87K 40.05% | 954.95K 35.29% | 840.67K 11.97% | 596.98K 28.99% | 702.51K 17.68% | 487.18K 30.65% | ||
average receivables | 3.42K - | 76.14K 2,122.98% | 131.09K 72.17% | 253.77K 93.59% | 195.40K 23.00% | -1.31M - | |||||
book value per share | 3.10 - | 1.28 58.65% | -4.58 457.08% | 38.27 936.48% | 27.74 27.52% | 12.70 54.23% | 7.47 41.15% | 5.27 29.45% | 2.49 52.72% | 0.89 64.31% | |
capex per share | -1.41 - | -0.68 51.41% | -0.06 - | -0.44 678.42% | -0.12 73.81% | -0.05 53.99% | -0.02 58.89% | -0.07 218.58% | -0.01 92.40% | ||
capex to depreciation | -7.39 - | -1.85 74.94% | -0.13 - | -1.46 1,044.68% | -0.38 74.10% | -0.31 18.05% | -0.20 35.45% | -0.86 331.26% | -0.12 85.77% | ||
capex to operating cash flow | 0.20 - | 0.16 19.43% | 0.00 - | 0.01 445.09% | 0.01 60.90% | 0.00 6.10% | 0.00 15.11% | 0.02 292.11% | 0.00 77.63% | ||
capex to revenue | -0.49 - | -0.09 80.72% | -0.02 - | -16.20 72,339.66% | |||||||
cash per share | 0.80 - | 0.10 87.77% | 0.74 657.81% | 40.64 5,376.77% | 28.73 29.30% | 16.46 42.69% | 7.53 54.26% | 4.62 38.60% | 1.69 63.43% | 0.45 73.66% | |
days of inventory on hand | 336.61 - | 54.24 83.89% | 62.06 14.42% | 404.92 552.48% | 3.48K - | ||||||
days payables outstanding | 16.20 - | 44.35 173.78% | 352.41 694.68% | 1.65K 367.72% | 477.57 - | ||||||
days sales outstanding | 7.11 - | 8.60K 120,807.97% | |||||||||
debt to assets | 1.94 - | 0.10 - | 0.08 20.63% | 0.05 32.57% | 0.06 11.77% | 0.09 47.32% | |||||
debt to equity | -1.06 - | 0.15 - | 0.10 35.63% | 0.06 34.15% | 0.08 20.51% | 0.10 36.59% | |||||
dividend yield | 0.33 - | 0.03 91.79% | 0.00 84.44% | 0.00 84.52% | 0.00 90.59% | ||||||
earnings yield | -0.14 - | -0.15 4.51% | -0.18 21.77% | -0.40 120.32% | -1.45 261.26% | -1.23 14.85% | -0.83 32.66% | -0.40 52.47% | -1.12 183.90% | -0.75 33.53% | |
enterprise value | 15.08M - | 15.22M 0.91% | 16.04M 5.42% | 7.80M 51.40% | 285.92K 96.33% | 7.13M 2,394.74% | 7.85M 10.09% | 19.54M 148.79% | 7.43M 61.99% | 11.05M 48.84% | |
enterprise value over ebitda | -18.08 - | -19.37 7.14% | -21.59 11.44% | -2.04 90.53% | -0.03 98.33% | -0.66 1,828.38% | -0.69 5.30% | -1.73 149.06% | -0.57 66.72% | -1.08 87.75% | |
ev to operating cash flow | -10.79 - | -18.06 67.31% | -12.19 32.48% | -2.36 80.63% | -0.04 98.43% | -0.83 2,137.28% | -0.73 12.21% | -1.76 140.92% | -0.58 66.89% | -1.16 99.04% | |
ev to sales | 26.96 - | 10.79 59.97% | 31.12 188.30% | 22.17 28.74% | 46.31 108.85% | ||||||
free cash flow per share | -8.56 - | -5.00 41.62% | -6.73 34.72% | -24.00 256.41% | -34.64 44.31% | -23.02 33.55% | -11.28 51.01% | -5.46 51.60% | -4.49 17.80% | -1.51 66.44% | |
free cash flow yield | -0.11 - | -0.06 41.62% | -0.09 34.72% | -0.25 186.01% | -1.15 367.58% | -0.69 40.67% | -0.75 9.74% | -0.39 47.55% | -1.10 179.54% | -0.71 35.57% | |
graham net net | 0.91 - | -0.86 194.09% | -6.24 626.81% | 35.22 664.14% | 25.02 28.96% | 10.41 58.40% | 6.48 37.73% | 3.92 39.57% | 1.43 63.42% | 0.17 88.12% | |
graham number | 27.90 - | 18.34 34.26% | 38.24 108.52% | 183.27 379.23% | 164.76 10.10% | 108.85 33.93% | 45.79 57.94% | 25.47 44.38% | 16.00 37.17% | 5.62 64.85% | |
income quality | 0.64 - | 0.37 42.29% | 0.47 28.21% | 0.61 29.50% | 0.79 28.08% | 0.65 17.90% | 0.92 42.30% | 0.99 7.81% | 0.97 2.16% | 0.95 2.04% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -4.60 - | -49.49 974.95% | -611.04 - | ||||||||
interest debt per share | 4.86 - | 8.17 - | 0.96 88.29% | 0.33 65.31% | 0.20 40.78% | 0.09 53.10% | |||||
inventory turnover | 1.08 - | 6.73 520.59% | 5.88 12.60% | 0.90 84.67% | 0.11 - | ||||||
invested capital | -1.06 - | 0.15 - | 0.10 35.63% | 0.06 34.15% | 0.08 20.51% | 0.10 36.59% | |||||
market cap | 15.24M - | 15.24M 0% | 15.24M 0% | 13.40M 12.07% | 6.76M 49.57% | 12.60M 86.46% | 14.39M 14.24% | 28.32M 96.74% | 11.77M 58.45% | 13.49M 14.65% | |
net current asset value | 306.81K - | -109.80K 135.79% | -1.19M 982.78% | 5.03M 523.40% | 5.97M 18.69% | 4.12M 31.05% | 6.62M 60.65% | 10.00M 51.16% | 6.46M 35.45% | 1.94M 69.99% | |
net debt to ebitda | 0.19 - | 0.02 87.02% | -1.08 4,549.28% | 1.47 235.61% | 0.77 47.40% | 0.50 34.70% | 0.58 14.46% | 0.78 34.40% | 0.34 56.71% | 0.24 29.14% | |
net income per share | -11.16 - | -11.67 4.51% | -14.21 21.77% | -39.01 174.56% | -43.49 11.50% | -41.48 4.63% | -12.47 69.94% | -5.47 56.15% | -4.57 16.51% | -1.58 65.37% | |
operating cash flow per share | -7.15 - | -4.31 39.69% | -6.73 56.11% | -23.95 255.57% | -34.20 42.80% | -22.90 33.02% | -11.22 51.00% | -5.44 51.57% | -4.42 18.75% | -1.50 66.03% | |
payables turnover | 22.53 - | 8.23 63.47% | 1.04 87.42% | 0.22 78.62% | 0.76 - | ||||||
receivables turnover | 51.33 - | 0.04 99.92% | |||||||||
research and ddevelopement to revenue | 1.56 - | 0.74 52.80% | 0.96 30.41% | 5.49 471.59% | 764.90 13,827.69% | ||||||
return on tangible assets | -3.10 - | -4.68 50.93% | -5.66 20.77% | -0.88 84.47% | -1.36 54.47% | -2.17 59.81% | -1.37 37.01% | -0.87 36.34% | -1.42 63.77% | -1.49 4.64% | |
revenue per share | 2.86 - | 7.22 152.09% | 2.64 63.44% | 2.55 3.35% | 0.03 98.93% | ||||||
roe | -3.60 - | -9.11 152.75% | 3.11 134.10% | -1.02 132.82% | -1.57 53.83% | -3.27 108.39% | -1.67 48.91% | -1.04 37.84% | -1.83 76.59% | -1.78 2.98% | |
roic | -3.28 - | -8.22 150.78% | -43.17 425.19% | -1.00 97.69% | -1.33 32.98% | -2.16 62.31% | -1.43 33.66% | -0.95 33.91% | -1.59 68.53% | -1.63 2.54% | |
sales general and administrative to revenue | 1.60 - | 0.87 45.91% | 2.99 244.85% | 7.82 161.62% | 607.80 7,668.00% | ||||||
shareholders equity per share | 3.10 - | 1.28 58.65% | -4.58 457.08% | 38.27 936.48% | 27.74 27.52% | 12.70 54.23% | 7.47 41.15% | 5.27 29.45% | 2.49 52.72% | 0.89 64.31% | |
stock based compensation to revenue | 0.46 - | 0.22 52.64% | 0.45 103.31% | ||||||||
tangible asset value | 605.33K - | 250.30K 58.65% | -893.77K 457.08% | 5.28M 690.25% | 6.25M 18.44% | 4.76M 23.81% | 7.17M 50.59% | 10.78M 50.42% | 7.20M 33.19% | 5.66M 21.45% | |
tangible book value per share | 3.10 - | 1.28 58.65% | -4.58 457.08% | 38.27 936.48% | 27.74 27.52% | 12.70 54.23% | 7.47 41.15% | 5.27 29.45% | 2.49 52.72% | 0.89 64.31% | |
working capital | 306.81K - | -109.80K 135.79% | -1.19M 982.79% | 5.03M 523.40% | 5.97M 18.69% | 4.46M 25.32% | 7.23M 61.96% | 10.55M 45.98% | 6.82M 35.33% | 2.13M 68.79% |
All numbers in (except ratios and percentages)